DNTH vs ED · rev $6.2M vs P/E 18, rev $15.26B
Dianthus Therapeutics Inc. (DNTH) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
DNTH currently screens at market cap $4.40B. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the DNTH and ED stock pages for the full models.
Not investment advice.